Stay updated on IDO Inhibitor+Gem/Nab-Pac in Metastatic Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the IDO Inhibitor+Gem/Nab-Pac in Metastatic Pancreatic Cancer Clinical Trial page.

Latest updates to the IDO Inhibitor+Gem/Nab-Pac in Metastatic Pancreatic Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedMinor UI/version change: the page footer now shows Revision: v3.4.2, replacing v3.4.1; this does not affect core content, data, or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check20 days agoChange DetectedRevision label updated from v3.4.0 to v3.4.1; a minor UI update that does not affect study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check27 days agoChange DetectedGlossary is now shown to help users understand trial terms. Minor metadata updates include capitalization adjustments for QC-related labels and a new Revision: v3.4.0 entry.SummaryDifference0.2%

- Check42 days agoChange DetectedMinor update to page revision label: addition of Revision v3.3.4 and removal of Revision v3.3.3, which does not affect the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedThe page now includes a detailed Locations section with state-specific sites (CA, GA, KY, MO, NJ, PA, SC, TN, UT, VT) and a revision note indicating v3.3.3. The HHS Vulnerability Disclosure link and references to v3.3.2 were removed.SummaryDifference1%

- Check91 days agoChange DetectedThe Publications note was updated to indicate auto-fill from PubMed and that items may not be about the study; the revision tag was updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to IDO Inhibitor+Gem/Nab-Pac in Metastatic Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IDO Inhibitor+Gem/Nab-Pac in Metastatic Pancreatic Cancer Clinical Trial page.